CV Sciences, Inc. is a publicly traded company trading on OTC, led by CEO Joseph D. Dowling.
Upcoming earnings announcement for CV Sciences, Inc.
Past 12 earnings reports for CV Sciences, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 26, 2026 | Q4 2025 | $0.00 | — | $3.3M | — | — |
| Nov 13, 2025 | Q3 2025 | $0.00 | — | $3.3M | — | — |
| Aug 13, 2025 | Q2 2025 | $0.00 | — | $3.6M | — | — |
| May 14, 2025 | Q1 2025 | $0.00 | — | $3.6M | — | — |
| Mar 27, 2025 | Q4 2024 | $0.00 | — | $3.9M | — | — |
| Nov 14, 2024 | Q3 2024 | $0.00 | — | $3.9M | — | — |
| Aug 13, 2024 | Q2 2024 | $0.00 | — | $4.0M | — | — |
| May 14, 2024 | Q1 2024 | $0.00 | — | $4.0M | — | — |
| Mar 28, 2024 | Q4 2023 | -$0.01 | — | $3.8M | — | — |
| Nov 14, 2023 | Q3 2023 | $0.00 | — | $4.1M | — | — |
| Aug 14, 2023 | Q2 2023 | -$0.01 | — | $4.0M | — | — |
| May 15, 2023 | Q1 2023 | $0.00 | — | $4.1M | — | — |
We use cookies for analytics. See our Privacy and Cookie Policy.